The sphingomyelin cycle: The flip side of the lipid signaling paradigm

Advances in Lipobiology

Volumn 2, Issue C, 1997, Pages 143-166

  Hannun, Yusuf A ^a   Jayadev, Supriya ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038322767     PISSN: 18745245     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5245(97)80008-0     Document Type: Article

References (89)

1. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem. 267 (1992) 20044-20050
2. Bell R.M. Protein kinase C activation by diacylglycerol second messengers. Cell 45 (1986) 631-632
3. Bielawska A., Crane H.M., Liotta D., Obeid L.M., and Hannun Y.A. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268 (1993) 26226-26232
4. Bielawska A., Linardic C.M., and Hannun Y.A. Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs. J. Biol. Chem. 267 (1992) 18493-18497
5. Bielawska A., Linardic C.M., and Hannun Y.H. Modulation of cell growth and differentiation by ceramide. FEBS Letters 307 (1992) 211-214
6. Brady R.O., and Koval G.J. The enzymatic synthesis of sphingosine. J. Biol. Chem. 233 (1958) 26-31
7. 20-dihydrosphingosines, ketodihydrosphingosines, and ceramides by microsomal preparations from mouse brain. J. Biol. Chem. 245 (1970) 335-341
8. Braun P.E., and Snell E.E. Biosynthesis of sphingolipid bases. J. Biol. Chem. 243 (1968) 3775-3783
9. Chatterjee S. Neutral sphingomyelinase. Adv. Lipid Res. 26 (1993) 25-48
10. Davis R.J., Girones N., and Faucher M. Two alternative mechanisms control the interconversion of functional states of the epidermal growth factor receptor. J. Biol. Chem. 263 (1988) 5373-5379
11. Dbaibo G.S., Obeid L.M., and Hannun Y.A. Tumor necrosis factor-α (TNF-a) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-a from activation of nuclear factor-κB. J. Biol. Chem. 268 (1993) 17762-17766
12. Desai N.N., Carlson R.O., Mattie M.E., Olivera A., Buckley N.E., Seki T., Brooker G., and Spiegel S. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J. Cell Biol. 121 (1993) 1385-1395
13. Desai N.N., and Spiegel S. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. Biochem. Biophys. Res. Comm. 181 (1991) 361-366
14. Diringer H., Marggraf W.D., Koch M.A., and Anderer F.A. Evidence for a new biosynthetic pathway of sphingomyelin in SV40 transformed mouse cells. Biochem. Biophys. Res. Comm. 47 (1972) 1345-1352
15. Dobrowsky R.T., and Hannun Y.H. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267 (1992) 5048-5051
16. Dobrowsky R.T., Kamibayashi C., Mumby M.C., and Hannun Y.A. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268 (1993) 15523-15530
17. Faucher M., Girones N., Hannun Y.A., Bell R.M., and Davis R. Regulation of the epidermal growth factor receptor phosphorylation state by sphingosine in A431 human epidermoid carcinoma cells. J. Biol. Chem. 263 (1988) 5319-5327
18. Fishbein J.D., Dobrowsky R.T., Bielawska A., Garrett S., and Hannun Y.A. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae. J. Biol. Chem. 268 (1993) 9255-9261
19. Fishman PH., Pacuszka T., and Orlandi P.A. Gangliosides as receptors for bacterial enterotoxins. Adv. Lipid Res. 25 (1993) 165-187
20. Fredman P. Glycosphingolipid tumor antigens. Adv. Lipid Res. 25 (1993) 213-234
21. Ghosh T.K., Bian J., and Gill D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248 (1990) 1653-1656
22. Goldkorn T., Dressler K.A., Muindi J., Radin N.S., Mendelsohn J., Menaldino D., Liotta D., and Kolesnick R.N. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. J. Biol. Chem. 266 (1991) 16092-16097
23. Goodrich D.W., and Lee W. Molecular characterization of the retinoblastome susceptibility gene. Biochim. Biophys. Acta 1155 (1993) 43-61
24. Hakomori S. Glycolipid changes associated with oncogenesis and ontogenesis, and the inhibition of the process of transformation by monovalent anti-glycolipid antibodies. Adv. Pathobiol. 7 (1980) 270-281
25. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Ann. Rev. Biochem. 50 (1981) 733-764
26. Hakomori S., and Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv. Lipid Res. 25 (1993) 147-162
27. Hakomori S., and Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J. Natl. Cancer Inst. 71 (1983) 231-251
28. Hannun Y.A. Encyclopedia of Human Biology. In: Dulbecco R. (Ed) (1991), Academic Press Inc., San Diego 179-189
29. Hannun Y.A., and Bell R.M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243 (1989) 500-507
30. Hannun Y.A., and Bell R.M. The sphingomyelin cycle: A prototypic sphingolipid signaling pathway. Adv. Lipid Res. 25 (1993) 27-41
31. Hannun Y.A., Loomis C.R., Merrill Jr. A.H., and Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261 (1986) 12604-12609
32. Hassler D.F., and Bell R.M. Ceramidases: Enzymology and metabolic roles. Adv. Lipid Res. 26 (1993) 49-57
33. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., and Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268 (1993) 11290-11295
34. Holleran W.M., Feingold K.R., Mao-Qiang M., Gao W.N., Lee J.M., and Elias P.M. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J. Lipid Res. 32 (1991) 1151-1158
35. Horn W.S., Smith J.L., Bills G.F., Raghoobar S.L., Helms G.L., Kurtz M.B., Marrinan J.A., Frommer B.R., Thornton R.A., and Mandala S.M. Sphingofungins E and F: Novel serine palmitoyltransferase inhibitors from Paecilomyces variotii. J. Antibiot. 45 (1992) 1692-1696
36. Inokuchi J., Momosaki K., Shimeno H., Nagamatsu A., and Radin N.S. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J. Cell. Physiol. 141 (1989) 573-583
37. Jarvis W.D., Kolesnick R.N., Forani RA., Taylor R.S., Gewirtz DA., and Grant S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Nat. Acad. Sci. USA 91 (1994) 73-77
38. Jayadev S., Linardic C.M., and Hannun Y.A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor a. J. Biol. Chem. 269 (1994) 5757
39. Kaneshiro T., Vesonder R.F., and Peterson R.E. Fumonisin-stimulated JV-acetyldihydrosphingosine, /V-acetylphytosphingosine, and phytosphingosine products of Pichia (Hansenula) ciferri, NRRL Y-1031. Curr. Microbiol. 24 (1992) 319-324
40. Karlsson K. On the chemistry and occurence of sphingolipid long-chain bases. Chem. Phys. Lipids 5 (1970) 6-43
41. Kim M., Linardic C.G., Obeid L., and Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor a and y-interferon. J. Biol. Chem. 266 (1991) 484-489
42. Kolesnick R.N. Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res. 30 (1991) 1-38
43. Krisnangkura K., and Sweeley C.C. Studies on the mechanism of 3-ketosphinganine synthetase. J. Biol. Chem. 251 (1976) 1597-1602
44. Lingwood C.A. Berotoxins and their glycolipid receptors. Adv. Lipid Res. 25 (1993) 189-211
45. Liu J., Mathias S., Yang Z., and Kolesnick R.N. Renaturation and tumor necrosis factor-a stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269 (1994) 3047-3052
46. Marggrag W.D., Anderer F.A., and Kanfer J.N. The formation of sphingomyelin from phosphatidylcholine in plasm membrane preparations from mouse fibroblasts. Biochim. Biophys. Acta 664 (1981) 61-73
47. Mathias S., Dressler K.A., and Kolesnick R.N. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor a. Proc. Nat. Acad. Sci. USA 88 (1991) 10009-10013
48. Mathias S., Younes A., Kan C., Orlow I., Joseph C., and Kolesnick R.N. Activation of the sphingomyelin signaling pathway in intact EL4 cells in a cell-free system by IL-Iβ. Science 259 (1993) 519-522
49. Medlock K.A., and Merrill Jr. A.H. Inhibition of serine palmitoyltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by β-chloroalanine. Biochem. 27 (1988) 7079-7084
50. Merrill Jr. A.H., and Jones D.D. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta 1044 (1990) 1-12
51. Merrill Jr. A.H., and Wang E. Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. J. Biol. Chem. 261 (1986) 3764-3769
52. Merrill Jr. A.H., van Echten G., Wang E., and Sandhoff K. Fumonisin B, inhibits sphingosine (sphinganine) /V-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268 (1993) 27299-27306
53. Mutch D.G., Powell C.B., Kao M., and Collins J.L. Resistance to cytolysis by tumor necrosis factor a in malignant gynecological cell lines is associated with the expression of protein (s) that prevent the activation of phospholipase A2 by tumor necrosis factor a. Cancer Res. 52 (1992) 866-872
54. Neale M.L., Fiera R.A., and Matthews N. Involvement of phospholipase A2 activation in tumour cell killing by tumor necrosis factor. Immunology 64 (1988) 81-85
55. Niculescu F., Rus H., Shin S., Lang T., and Shin ML. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immun. 150 (1993) 214-224
56. Nudelman E., Kannagi R., Hakomori S., Parsons M., Lipinski M., Wiels J., Fellous M., and Tursz T. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220 (1983) 509-511
57. Obeid L.M., Linardic C.M., Karolak L.A., and Hannun Y.A. Programmed cell death induced by ceramide. Science 259 (1993) 1769-1771
58. Okada Y., Matsuura H., and Hakomori S. Inhibition of tumor cell growth by aggregation of tumor-associated glycolipid antigen: A close functional association between gangliotriaosylceramide and transferrin receptor in mouse lymphoma L-5178Y. Cancer Res. 45 (1985) 2793-2801
59. Okada Y., Mugnai G., Bremer E.G., and Hakomori S. Glycosphingolipids in detergent-insoluble substrate attachment matrix (DISAM) prepared from substrate attachment material (SAM). Their possible role in regulating cell adhesion. Exp. Cell Res. 155 (1984) 448-456
60. Okazaki T., Bell R.M., and Hannun Y.A. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. J. Biol. Chem. 264 (1989) 19076-19080
61. Okazaki T., Bielawska A., Bell R.M., and Hannun Y.A. Role of ceramide as a lipid mediator of la,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265 (1990) 15823-15831
62. Okazaki T., Bielawska A., Domae N., Bell R.M., and Hannun Y.A. Characteristics and partial purification of a novel cytosoliC, magnesium-independent, neutral sphingomyelinase activated in the early signal transaction of la,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 269 (1994) 4070-4077
63. Olivera A., and Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365 (1993) 557-560
64. Ong D.E., and Brady R.N. In vivo studies on the introduction of the 4-f-double bond of the sphingenine moiety of rat brain ceramides. J. Biol. Chem. 248 (1973) 3884-3888
65. Pascher I. Molecular arrangements in sphingolipids. Comformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. Biochim. Biophys. Acta 455 (1976) 433-451
66. Ramachandran C.K., Murray D.K., and Nelson D.H. Daxamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts. Biochem. Biophys. Res. Comm. 167 (1990) 607-613
67. Rosenwald A.G., Machamer C.E., and Pagano R.E. Effects of a sphingolipid synthesis inhibitor on membrane transport through the secretory pathway. Biochem. 31 (1992) 3581-3590
68. Sandhoff K., and van Echten G. Ganglioside metabolism - Topology and regulation. Adv. Lipid Res. 26 (1993) 119-142
69. Schutze S., Berkovi C.D., Tomsing O., Unger C., and Kronke M. Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C. J. Exp. Med. 174 (1991) 975-988
70. Schutze S., Potthoff K., Machleidt T., Berkovi C.D., Wiegmann K., and Kronke M. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71 (1992) 765-776
71. Shier W.T. Sphingosine analogs: An emerging new class of toxins that includes the fumonisins. J. Toxicol. Toxin Rev. 11 (1992) 241-257
72. Spence M.W. Sphingomyelinases. Adv. Lipid Res. 26 (1993) 3-23
73. Stoffel W., and Bister K. Studies on the desaturation of sphinganine. Hoppe-Seyler's Z. Physiol. Chem. 355 (1974) 911-923
74. Stoffel W., LeKim D., and Sticht G. Stereospecificity of the NADPH-dependent reduction of 3-oxodihydrophingosine (2-amino-l-hydroxyoctadecane-3-one). Hoppe-Seyler's Z Physiol. Chem. 349 (1968) 1637-1644
75. Sufifys P., Beyaert R., Van Roy F., and Fiers W. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochim. Biophys. Acta 149 (1987) 735-743
76. Sundaram K.S., and Lev M. Comparative inhibition of bacterial and microsomal 3-ketodihydrosphingosine sythetase by L-cycloserine and other inhibitors. Antimicrob. Agents Chemother. 26 (1984) 211-213
77. Tettamanti G., and Riboni L. Gangliosides and modulation of the function of neural cells. Adv. Lipid Res. 25 (1993) 235-267
78. Thudichum J.L.W. A Treatise on the Chemical Constitution of the Brain (1962), Archon Books, Hamden, CT
79. Ullman MD., and Radin N.S. The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. J. Biol. Chem. 249 (1974) 1506-1512
80. Vance D.E., and Vance J.E. Biochemistry of Lipids and Membranes (1985), The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA
81. Vilcek J., and Lee T.H. Tumor necrosis factor: New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266 (1991) 7313-7316
82. Wang E., Norred W.P., Bacon C.W., Riley R.T., and Merrill Jr. A.H. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266 (1991) 14486-14490
83. Wang E., Ross P.F., Wilson T.M., Riley R.T., and Merrill Jr. A.H. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122 (1992) 1706-1716
84. Williams R.D., Sgoutas D.S., Zaatri G.S., and Santoianni R.A. Inhibition of serine palmitoyltransferase activity in rabbit aorta by L-cycloserine. J. Lipid Res. 28 (1987) 1478-1481
85. Williams R.D., Wang E., and Merrill Jr. A.H. Enzymology of long-chain base synthesis by liver: Characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys 228 (1984) 282-291
86. Zhang H., Buckley N.E., Gibson K., and Spiegel S. Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway. J. Biol. Chem. 265 (1990) 76-81
87. Zhang H., Desai N.N., Murphey J.M., and Spiegel S. Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells. J. Biol. Chem. 265 (1990) 21309-21316
88. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., and Spiegel S. Sphingosine-1-phosphate, a novel lipid, invoved in cellular proliferation. J. Cell Biol. 114 (1991) 155-167
89. Zweerink M.M., Edison A.M., Wells G.B., Pinto W., and Lester R.L. Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase. J. Biol. Chem. 267 (1992) 25032-25038